If reducing dose does not resolve symptoms within a few weeks, consult a healthcare provider
Resistance after CF-based NAC may be driven predominantly by the selection or enrichment of pre-existing resistant subclones or cell states, rather than by extensive therapy-induced reprogramming
Budak , Machnik G, Budak RJ, abuzek K, Bodys A, Okopie B
However, when it comes to how much weight you can lose, you can expect about 1112% weight loss with Foundayo, making it less effective than weekly injections like Wegovy (15%) and Zepbound (up to 2022%)
Healthcare professionals should consult the complete Product Monograph for detailed information on warnings, precautions, adverse reactions, and patient monitoring requirements
Research-grade material distributed by Rexar within the European Union